These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 31472818

  • 1. The Use of Renin-Angiotensin System Inhibitors in Patients With Chronic Kidney Disease.
    Leon SJ, Tangri N.
    Can J Cardiol; 2019 Sep; 35(9):1220-1227. PubMed ID: 31472818
    [Abstract] [Full Text] [Related]

  • 2. Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials.
    Xie X, Liu Y, Perkovic V, Li X, Ninomiya T, Hou W, Zhao N, Liu L, Lv J, Zhang H, Wang H.
    Am J Kidney Dis; 2016 May; 67(5):728-41. PubMed ID: 26597926
    [Abstract] [Full Text] [Related]

  • 3. An update of the blockade of the renin angiotensin aldosterone system in clinical practice.
    Márquez DF, Ruiz-Hurtado G, Ruilope LM, Segura J.
    Expert Opin Pharmacother; 2015 May; 16(15):2283-92. PubMed ID: 26389772
    [Abstract] [Full Text] [Related]

  • 4. [Classical nephroprotection: Renin angiotensin aldosterone system inhibitors].
    Egocheaga MI, Drak Y, Otero V.
    Semergen; 2023 Jun; 49 Suppl 1():102018. PubMed ID: 37355297
    [Abstract] [Full Text] [Related]

  • 5. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.
    Shenoy SV, Nagaraju SP, Bhojaraja MV, Prabhu RA, Rangaswamy D, Rao IR.
    Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194
    [Abstract] [Full Text] [Related]

  • 6. Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?
    Sarafidis PA, Ruilope LM.
    Kidney Int; 2014 Mar; 85(3):536-46. PubMed ID: 24048382
    [Abstract] [Full Text] [Related]

  • 7. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW, Liu JS, Hung SC, Kuo KL, Chang YK, Chen YC, Hsu CC, Tarng DC.
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [Abstract] [Full Text] [Related]

  • 9. Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers.
    Ku E, McCulloch CE, Vittinghoff E, Lin F, Johansen KL.
    J Am Heart Assoc; 2018 Oct 02; 7(19):e009992. PubMed ID: 30371331
    [Abstract] [Full Text] [Related]

  • 10. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis.
    Zhao HJ, Li Y, Liu SM, Sun XG, Li M, Hao Y, Cui LQ, Wang AH.
    Ren Fail; 2016 Jul 02; 38(6):849-56. PubMed ID: 27055479
    [Abstract] [Full Text] [Related]

  • 11. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
    Weir MR, Lakkis JI, Jaar B, Rocco MV, Choi MJ, Kramer HJ, Ku E.
    Am J Kidney Dis; 2018 Dec 02; 72(6):873-884. PubMed ID: 30201547
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC, Wu YT, Yang WC, Tsai MJ, Liu JS, Yang CY, Li SY, Ou SM, Tarng DC, Hsu CC.
    PLoS One; 2017 Dec 02; 12(12):e0189126. PubMed ID: 29216260
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases.
    Weinberger MH, Luft FC.
    Kidney Int; 2006 Dec 02; 70(12):2051-3. PubMed ID: 17136130
    [Abstract] [Full Text] [Related]

  • 14. Use of renin-angiotensin-aldosterone system blockade in controversial chronic kidney disease populations.
    García-Prieto AM, Verdalles Ú, Goicoechea M.
    Med Clin (Barc); 2021 Jun 11; 156(11):561-567. PubMed ID: 33757646
    [Abstract] [Full Text] [Related]

  • 15. The Impact of Renin-Angiotensin System Blockade on Renal Outcomes and Mortality in Pre-Dialysis Patients with Advanced Chronic Kidney Disease.
    Oh YJ, Kim SM, Shin BC, Kim HL, Chung JH, Kim AJ, Ro H, Chang JH, Lee HH, Chung W, Lee C, Jung JY.
    PLoS One; 2017 Jun 11; 12(1):e0170874. PubMed ID: 28122064
    [Abstract] [Full Text] [Related]

  • 16. When should we start and stop ACEi/ARB in paediatric chronic kidney disease?
    Chan EY, Ma AL, Tullus K.
    Pediatr Nephrol; 2021 Jul 11; 36(7):1751-1764. PubMed ID: 33057769
    [Abstract] [Full Text] [Related]

  • 17. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR, Bakris GL, Gross C, Mayo MR, Garza D, Stasiv Y, Yuan J, Berman L, Williams GH.
    Kidney Int; 2016 Sep 11; 90(3):696-704. PubMed ID: 27350174
    [Abstract] [Full Text] [Related]

  • 18. Arterial hypertension and proteinuria in pediatric chronic kidney disease.
    Simonetti GD, Bucher BS, Tschumi S, Lava SA, Bianchetti MG.
    Minerva Pediatr; 2012 Apr 11; 64(2):171-82. PubMed ID: 22495191
    [Abstract] [Full Text] [Related]

  • 19. Transforming the Care of Patients with Diabetic Kidney Disease.
    Brosius FC, Cherney D, Gee PO, Harris RC, Kliger AS, Tuttle KR, Quaggin SE, DKD-Collaborative ASN Taskforce.
    Clin J Am Soc Nephrol; 2021 Oct 11; 16(10):1590-1600. PubMed ID: 34103350
    [Abstract] [Full Text] [Related]

  • 20. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P.
    Nephrol Ther; 2017 Apr 11; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.